Paper Details 
Original Abstract of the Article :
(1) Ivermectin is the first oral drug to be licensed in France for the treatment of scabies. (2) In common scabies, three small trials suggest that ivermectin is about as effective as topical preparations. (3) Several cohort studies have shown that ivermectin can control outbreaks of scabies (especi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/12378743

データ提供:米国国立医学図書館(NLM)

Ivermectin: A New Weapon Against Scabies

This study examines the use of ivermectin, a medication commonly used to treat parasitic infections, as a treatment for scabies. It's like finding a new and effective way to protect a desert oasis from harmful pests. The researchers explore the effectiveness and safety of ivermectin for treating this skin condition.

A Promising New Treatment

The study suggests that ivermectin may be an effective and convenient treatment for scabies. It's like discovering a new and powerful weapon against a persistent desert pest. Its oral administration makes it easier to treat, especially during outbreaks.

Navigating the Desert of Treatment Options

The study highlights the importance of considering various treatment options for scabies. It's like choosing the best route to cross a vast and unpredictable desert. Ivermectin offers a new and potentially valuable tool in the fight against this common condition.

Dr. Camel's Conclusion

This study demonstrates the importance of ongoing research to find new and improved treatments for diseases. It's a reminder that the desert of medicine is always being explored, with new discoveries emerging to improve our understanding and care.
Date :
  1. Date Completed 2002-10-28
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

12378743

DOI: Digital Object Identifier

12378743

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.